This was reported a few days after the company announced poor and long-awaited Phase III clinical trial results for a heart disease drug, which were also worse than expected. Read more The district court will announce the decision in the case of Irma Gajauskaitė regarding riots and incitement on October 22 Novartis shares in Zurich…
A claim is spreading on social networks that the pharmaceutical industry spends 19 times more on advertising than on scientific research. The impressive-sounding figure is not fabricated –…
US pharmaceutical giant Pfizer reported second-quarter losses on Tuesday due to write-downs from unfavorable clinical results, despite overall…
German agrochemical giant Bayer announced on Tuesday that it again made a profit in the second quarter. This was influenced by successful agricultural business operations and lower legal expenses…
Didžiosios Britanijos farmacijos milžinė „AstraZeneca“ derasi su JAV konkurente „Bristol Myers Squibb“ (BMS) dėl beveik 400 mlrd. JAV dolerių vertės susijungimo, skelbia finansų…
British pharmaceutical giant AstraZeneca announced on Monday that strong growth in cancer drug sales boosted its net profit in the second quarter of this year.
Danish pharmaceutical giant Novo Nordisk announced on Tuesday that it had sued its main US competitor Eli Lilly over “false and fundamentally misleading” advertising…
Swiss pharmaceutical giant Novartis announced on Tuesday that the group’s sales in the second quarter of this year exceeded expectations, driven by various new products.